Incyte Stock Rises on QIAGEN Deal to Advance Blood Cancer Diagnostics

• click to rate

  Posted by Two Blokes Jun 17 - Filed in Stock - 7 views
  
  INCY jumps 5.1% on a global QIAGEN deal to develop a companion diagnostic for its mutCALR-targeting cancer therapy.